1. Home
  2. TIC vs NEO Comparison

TIC vs NEO Comparison

Compare TIC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acuren Corporation

TIC

Acuren Corporation

N/A

Current Price

$11.24

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$16.76

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIC
NEO
Founded
1991
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
TIC
NEO
Price
$11.24
$16.76
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$12.64
★ $23.40
AVG Volume (30 Days)
★ 1.8M
1.7M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $1,530,296,000.00
N/A
Revenue This Year
$47.20
$11.12
Revenue Next Year
$6.28
$9.68
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.36
$7.07
52 Week High
$11.86
$20.15

Technical Indicators

Market Signals
Indicator
TIC
NEO
Relative Strength Index (RSI) 65.13 47.76
Support Level $8.87 $15.73
Resistance Level N/A $17.19
Average True Range (ATR) 0.56 0.87
MACD 0.12 0.03
Stochastic Oscillator 84.46 41.78

Price Performance

Historical Comparison
TIC
NEO

About TIC Acuren Corporation

TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: